124 related articles for article (PubMed ID: 19609102)
1. Frequency and gene expression profile of regulatory T cells in renal cell carcinoma.
Jeron A; Pfoertner S; Bruder D; Geffers R; Hammerer P; Hofmann R; Buer J; Schrader AJ
Tumour Biol; 2009; 30(3):160-70. PubMed ID: 19609102
[TBL] [Abstract][Full Text] [Related]
2. Frequency of regulatory T cells in renal cell carcinoma patients and investigation of correlation with survival.
Griffiths RW; Elkord E; Gilham DE; Ramani V; Clarke N; Stern PL; Hawkins RE
Cancer Immunol Immunother; 2007 Nov; 56(11):1743-53. PubMed ID: 17487490
[TBL] [Abstract][Full Text] [Related]
3. Microarray gene expression profiling and analysis in renal cell carcinoma.
Liou LS; Shi T; Duan ZH; Sadhukhan P; Der SD; Novick AA; Hissong J; Skacel M; Almasan A; DiDonato JA
BMC Urol; 2004 Jun; 4():9. PubMed ID: 15212686
[TBL] [Abstract][Full Text] [Related]
4. Regulatory T cells, interleukin (IL)-6, IL-8, vascular endothelial growth factor (VEGF), CXCL10, CXCL11, epidermal growth factor (EGF) and hepatocyte growth factor (HGF) as surrogate markers of host immunity in patients with renal cell carcinoma.
Polimeno M; Napolitano M; Costantini S; Portella L; Esposito A; Capone F; Guerriero E; Trotta A; Zanotta S; Pucci L; Longo N; Perdonà S; Pignata S; Castello G; Scala S
BJU Int; 2013 Sep; 112(5):686-96. PubMed ID: 23495770
[TBL] [Abstract][Full Text] [Related]
5. Expression of apoptotic regulatory molecules in renal cell carcinoma: elevated expression of Fas ligand.
Olive C; Cheung C; Nicol D; Falk MC
Immunol Cell Biol; 1999 Feb; 77(1):11-8. PubMed ID: 10101681
[TBL] [Abstract][Full Text] [Related]
6. Frequency of regulatory T cells in peripheral blood and in tumour-infiltrating lymphocytes correlates with poor prognosis in renal cell carcinoma.
Liotta F; Gacci M; Frosali F; Querci V; Vittori G; Lapini A; Santarlasci V; Serni S; Cosmi L; Maggi L; Angeli R; Mazzinghi B; Romagnani P; Maggi E; Carini M; Romagnani S; Annunziato F
BJU Int; 2011 May; 107(9):1500-6. PubMed ID: 20735382
[TBL] [Abstract][Full Text] [Related]
7. Tumor-infiltrating regulatory T cells are positively correlated with angiogenic status in renal cell carcinoma.
Ning H; Shao QQ; Ding KJ; Gao DX; Lu QL; Cao QW; Niu ZH; Fu Q; Zhang CH; Qu X; Lü JJ
Chin Med J (Engl); 2012 Jun; 125(12):2120-5. PubMed ID: 22884140
[TBL] [Abstract][Full Text] [Related]
8. Regulatory T-cells and associated pathways in metastatic renal cell carcinoma (mRCC) patients undergoing DC-vaccination and cytokine-therapy.
Schwarzer A; Wolf B; Fisher JL; Schwaab T; Olek S; Baron U; Tomlinson CR; Seigne JD; Crosby NA; Gui J; Hampton TH; Fadul CE; Heaney JA; Ernstoff MS
PLoS One; 2012; 7(10):e46600. PubMed ID: 23118856
[TBL] [Abstract][Full Text] [Related]
9. Tumor-infiltrating Foxp3-CD4+CD25+ T cells predict poor survival in renal cell carcinoma.
Siddiqui SA; Frigola X; Bonne-Annee S; Mercader M; Kuntz SM; Krambeck AE; Sengupta S; Dong H; Cheville JC; Lohse CM; Krco CJ; Webster WS; Leibovich BC; Blute ML; Knutson KL; Kwon ED
Clin Cancer Res; 2007 Apr; 13(7):2075-81. PubMed ID: 17404089
[TBL] [Abstract][Full Text] [Related]
10. CD4+ CD25+ regulatory T cells in human pregnancy: development of a Treg-MLC-ELISPOT suppression assay and indications of paternal specific Tregs.
Mjösberg J; Berg G; Ernerudh J; Ekerfelt C
Immunology; 2007 Apr; 120(4):456-66. PubMed ID: 17229266
[TBL] [Abstract][Full Text] [Related]
11. Expression of cytokine mRNA transcripts in renal cell carcinoma.
Olive C; Cheung C; Nicol D; Falk MC
Immunol Cell Biol; 1998 Aug; 76(4):357-62. PubMed ID: 9723777
[TBL] [Abstract][Full Text] [Related]
12. miR-29b and miR-198 overexpression in CD8+ T cells of renal cell carcinoma patients down-modulates JAK3 and MCL-1 leading to immune dysfunction.
Gigante M; Pontrelli P; Herr W; Gigante M; D'Avenia M; Zaza G; Cavalcanti E; Accetturo M; Lucarelli G; Carrieri G; Battaglia M; Storkus WJ; Gesualdo L; Ranieri E
J Transl Med; 2016 Apr; 14():84. PubMed ID: 27063186
[TBL] [Abstract][Full Text] [Related]
13. Regulatory T cells, dendritic cells and neutrophils in patients with renal cell carcinoma.
Minárik I; Lašťovička J; Budinský V; Kayserová J; Spíšek R; Jarolím L; Fialová A; Babjuk M; Bartůňková J
Immunol Lett; 2013 May; 152(2):144-50. PubMed ID: 23721909
[TBL] [Abstract][Full Text] [Related]
14. Expression profiles of regulatory and helper T-cell-associated genes in nasal polyposis.
Li CW; Zhang KK; Li TY; Lin ZB; Li YY; Curotto de Lafaille MA; Shi L; Wang DY
Allergy; 2012 Jun; 67(6):732-40. PubMed ID: 22462754
[TBL] [Abstract][Full Text] [Related]
15. CD4(+)CD25 (+) regulatory T cells in human lupus erythematosus.
Kuhn A; Beissert S; Krammer PH
Arch Dermatol Res; 2009 Jan; 301(1):71-81. PubMed ID: 18985367
[TBL] [Abstract][Full Text] [Related]
16. Gene signatures of progression and metastasis in renal cell cancer.
Jones J; Otu H; Spentzos D; Kolia S; Inan M; Beecken WD; Fellbaum C; Gu X; Joseph M; Pantuck AJ; Jonas D; Libermann TA
Clin Cancer Res; 2005 Aug; 11(16):5730-9. PubMed ID: 16115910
[TBL] [Abstract][Full Text] [Related]
17. Expression of genes involved in chemoresistance, proliferation and apoptosis in clinical samples of renal cell carcinoma and correlation with clinical outcome.
Oudard S; Levalois C; Andrieu JM; Bougaran J; Validire P; Thiounn N; Poupon MF; Fourme E; Chevillard S
Anticancer Res; 2002; 22(1A):121-8. PubMed ID: 12017273
[TBL] [Abstract][Full Text] [Related]
18. A possible pathogenic role of CD4+CD25+ T-regulatory cells in psoriasis.
Shehata IH; Elghandour TM
Egypt J Immunol; 2007; 14(1):21-31. PubMed ID: 18689278
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the response of dendritic cells and regulatory T cells to tumor antigens in patients with renal cell carcinoma.
Hou MM; Chang JW; Pang ST; Chiang YJ; Shen YC; Liao SK; Hsieh JJ; Yeh KY; Chang NJ; Chuang CK
Chang Gung Med J; 2010; 33(1):25-35. PubMed ID: 20184792
[TBL] [Abstract][Full Text] [Related]
20. Neuropilin 1 deficiency on CD4+Foxp3+ regulatory T cells impairs mouse melanoma growth.
Hansen W; Hutzler M; Abel S; Alter C; Stockmann C; Kliche S; Albert J; Sparwasser T; Sakaguchi S; Westendorf AM; Schadendorf D; Buer J; Helfrich I
J Exp Med; 2012 Oct; 209(11):2001-16. PubMed ID: 23045606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
